mevastatin has been researched along with 3-hydroxy-3-methylglutaryl-coenzyme a in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Umezawa, K | 1 |
Abeles, RH; Nakamura, CE | 1 |
Krieger, M | 1 |
Mabuchi, H | 1 |
Liang, Y; Mirnics, ZK; Nylander, KD; Portugal, CF; Rudzinski, M; Saragovi, HU; Schor, NF; Yan, C; Zaccaro, C | 1 |
Coselli, J; Gan, Y; Wang, J; Wang, XL | 1 |
Chen, H; Fang, D; Jiang, D; Ma, G; Tian, C; Zhou, J | 1 |
Baumgarten, G; Frede, S; Hilbert, T; Hoeft, A; Klaschik, S; Knuefermann, P; Poth, J | 1 |
Dinesh, N; Singh, S; Soumya, N | 1 |
2 review(s) available for mevastatin and 3-hydroxy-3-methylglutaryl-coenzyme a
Article | Year |
---|---|
[Biological activity of oncogene function inhibitors isolated from microorganisms].
Topics: Acyl Coenzyme A; Animals; Bacteria; Furans; Genistein; Hydroquinones; Isoflavones; Lovastatin; Oncogene Proteins; Phosphatidylinositols; Protein-Tyrosine Kinases | 1992 |
[Clinical studies on hyperlipidemia].
Topics: Acyl Coenzyme A; Anticholesteremic Agents; Blood Component Removal; Clinical Trials as Topic; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin | 1999 |
7 other study(ies) available for mevastatin and 3-hydroxy-3-methylglutaryl-coenzyme a
Article | Year |
---|---|
Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
Topics: Acyl Coenzyme A; Coenzyme A; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lovastatin; Mathematics; NADP; Naphthalenes; Pyrans; Pyrones; Saccharomyces cerevisiae | 1985 |
The use of amphotericin B to detect inhibitors of cellular cholesterol biosynthesis.
Topics: Acyl Coenzyme A; Amphotericin B; Animals; Cell Line; Cell Survival; Cholesterol; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Farnesyl-Diphosphate Farnesyltransferase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Lovastatin; Mevalonic Acid; Naphthalenes | 1983 |
Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells.
Topics: Acyl Coenzyme A; Analysis of Variance; Animals; Antibodies, Monoclonal; Apoptosis; Blotting, Northern; Blotting, Western; Cell Count; Cholesterol; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Geranyltranstransferase; Lovastatin; Microarray Analysis; Nucleic Acid Synthesis Inhibitors; Oxidoreductases Acting on CH-CH Group Donors; PC12 Cells; Phosphorylation; Rats; Receptor, Nerve Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Zinostatin | 2005 |
Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells.
Topics: Acyl Coenzyme A; Apoptosis; Dose-Response Relationship, Drug; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin | 2008 |
Luminol electrochemiluminescence for the analysis of active cholesterol at the plasma membrane in single mammalian cells.
Topics: Acyl Coenzyme A; Amides; Animals; Anticholesteremic Agents; Biological Transport; Cell Line; Cell Membrane; Cholesterol; Cholesterol Oxidase; Electrochemical Techniques; Electrodes; Hydrogen Peroxide; Lovastatin; Luminescent Measurements; Luminol; Macrophages; Mice; Organosilicon Compounds; Single-Cell Analysis; Sterol O-Acyltransferase | 2013 |
Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells.
Topics: Acyl Coenzyme A; Angiopoietin-2; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Exocytosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Simvastatin; Weibel-Palade Bodies | 2013 |
Antileishmanial effect of mevastatin is due to interference with sterol metabolism.
Topics: Acyl Coenzyme A; Cell Line; Enzyme Inhibitors; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Lovastatin; Protozoan Proteins; Sterols | 2015 |